DECITABINE

作品数：42被引量：73H指数：5
导出分析报告
相关领域：医药卫生更多>>
相关作者：王琳许小平曹蕾张浩朱尔佳更多>>
相关机构：台湾神隆股份有限公司复旦大学广东药学院连云港杰瑞药业有限公司更多>>
相关期刊：《Cellular & Molecular Immunology》《当代医学》《药学进展》《Oncology and Translational Medicine》更多>>
相关基金：国家自然科学基金国家重点基础研究发展计划更多>>
-
在结果中检索

检索结果分析

结果分析中...
选择条件：
  • 期刊=World Journal of Clinical Casesx
共 条 记 录，以下是1-4
全选清除导出
参考文献引证文献引用追踪
视图：
排序：
T/myeloid mixed-phenotype acute leukemia treated with venetoclax and decitabine:A case report
《World Journal of Clinical Cases》2023年第26期6200-6205,共6页Sungwoo Park Eun Jeong Jeong Jung Hun Kang Gyeong-Won Lee Se-Il Go Dong-Hyun Lee Eun-Ha Koh 
BACKGROUND Mixed-phenotype acute leukemia(MPAL)is characterized by acute undifferentiated leukemia with blasts co-expressing myeloid and lymphoid antigens.However,consensus regarding the ideal management strategy for ...
关键词：Mixed-phenotype acute leukemia Venetoclax DECITABINE Case report 
Acute myelomonocytic leukemia and T-lymphoblastic lymphoma as simultaneous bilineage hematologic malignancy treated with decitabine:A case report
《World Journal of Clinical Cases》2023年第21期5129-5135,共7页So-Yeon Jeon Na-Ri Lee Seungah Cha Ho-Young Yhim Jae-Yong Kwak Kyu Yun Jang Namsu Kim Yong Gon Cho Chang-Hoon Lee 
BACKGROUND Simultaneous bilineage hematologic malignancies are rare;however,several cases of acute myeloid leukemia(AML)and T-lymphoblastic lymphoma(T-LBL)cooccurrence have been reported.A standard treatment for simul...
关键词：Simultaneous bilineage hematologic malignancies Acute myelomonocytic leukemia T-lymphoblastic lymphoma DECITABINE Pulmonary thromboembolism Case report 
Treatment of refractory/relapsed extranodal NK/T cell lymphoma with decitabine plus anti-PD-1:A case report被引量：1
《World Journal of Clinical Cases》2022年第28期10193-10200,共8页Lin-Jie Li Jun-Yu Zhang 
Supported by the Medical Health Science and Technology Project of Zhejiang Province Health Commission,No.2020376298。
BACKGROUND Extranodal natural killer/T cell lymphoma,nasal type(ENKL) is a highly aggressive malignancy characterized by its association with Epstein-Barr virus(EBV) and extranodal involvement,which shows a poor clini...
关键词：NK-T cell lymphoma Refractory/relapsed Anti-PD-1 DECITABINE Case report 
Relapsed/refractory classical Hodgkin lymphoma effectively treated with low-dose decitabine plus tislelizumab:A case report被引量：1
《World Journal of Clinical Cases》2021年第21期6041-6048,共8页Xiao-Sheng Ding Lan Mi Yu-Qin Song Wei-Ping Liu Hui Yu Ning-Jing Lin Jun Zhu 
BACKGROUND Academic studies have proved that anti-programmed death-1(PD-1)monoclonal antibodies demonstrated remarkable activity in relapsed/refractory classical Hodgkin lymphoma(cHL).However,most patients ultimately ...
关键词：IMMUNOTHERAPY Hypomethylating agent Classical Hodgkin lymphoma SURVIVAL Case report 
全选清除导出
共1页<1>
检索报告 对象比较 聚类工具 使用帮助 返回顶部